| Name | Recombinant Human CD316 (C-6His) |
| Purity | Greater than 95% as determined by reducing SDS-PAGE |
| Endotoxin level | <1 EU/µg as determined by LAL test. |
| Construction | Recombinant Human Immunoglobulin Superfamily Member 8 is produced by our Mammalian expression system and the target gene encoding Arg28-Thr579 is expressed with a 6His tag at the C-terminus. |
| Accession # | Q969P0 |
| Host | Human Cells |
| Species | Human |
| Predicted Molecular Mass | 59.6 KDa |
| Buffer | Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 10% Trehalose, 150mM NaCl, 0.05% Tween80, pH8.0. |
| Form | Lyophilized |
| Shipping | The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below. |
| Stability&Storage | Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
Alternative Names
Immunoglobulin Superfamily Member 8; IgSF8; CD81 Partner 3; Glu-Trp-Ile EWI Motif-Containing Protein 2; EWI-2; Keratinocytes-Associated Transmembrane Protein 4; KCT-4; LIR-D1; Prostaglandin Regulatory-Like Protein; PGRL; CD316; IGSF8; CD81P3; EWI2; KCT4
Background
Immunoglobulin Superfamily Member 8 (IGSF8) is a single-pass membrane protein. IGSF8 contains four Ig-like C2 type domains. The Ig-like C2-type domains 3 and 4 are required for interactions with CD81. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain. It also may play a role on integrin-dependent morphology and motility functions.
Note
For Research Use Only , Not for Diagnostic Use.
